NCT02722018View on ClinicalTrials.gov

Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 6, 2016

Primary Completion Date

September 13, 2016

Study Completion Date

September 13, 2016

Conditions
Healthy Volunteer
Interventions
DRUG

GDC-0810 Phase II Tablet

Participants will receive dose level A (in Parts 1 and 2) or dose level B (in Part 3) tablets.

DRUG

GDC-0810 Phase III Prototype Tablet

Participants will receive dose level A (in Parts 1 and 2) or dose level B (in Part 3) tablets.

Trial Locations (1)

NG11 6JS

Quotient Clinical Ltd, Clinical Research Unit, Nottingham

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY